Weiss JM - Search Results

1

LTβR signalling preferentially accelerates oncogenic AKT-initiated liver tumours.

Scarzello AJ, Jiang Q, Back T, Dang H, Hodge D, Hanson C, Subleski J, Weiss JM, Stauffer JK, Chaisaingmongkol J, Rabibhadana S, Ruchirawat M, Ortaldo J, Wang XW, Norris PS, Ware CF, Wiltrout RH. Scarzello AJ, et al. Among authors: weiss jm. Gut. 2016 Oct;65(10):1765-75. doi: 10.1136/gutjnl-2014-308810. Epub 2015 Jul 23. Gut. 2016. PMID: 26206664 Free PMC article.

2

TCR-dependent and -independent activation underlie liver-specific regulation of NKT cells.

Subleski JJ, Hall VL, Wolfe TB, Scarzello AJ, Weiss JM, Chan T, Hodge DL, Back TC, Ortaldo JR, Wiltrout RH. Subleski JJ, et al. Among authors: weiss jm. J Immunol. 2011 Jan 15;186(2):838-47. doi: 10.4049/jimmunol.1001735. Epub 2010 Dec 10. J Immunol. 2011. PMID: 21148802 Free PMC article.

3

Coactivation of AKT and β-catenin in mice rapidly induces formation of lipogenic liver tumors.

Stauffer JK, Scarzello AJ, Andersen JB, De Kluyver RL, Back TC, Weiss JM, Thorgeirsson SS, Wiltrout RH. Stauffer JK, et al. Among authors: weiss jm. Cancer Res. 2011 Apr 1;71(7):2718-27. doi: 10.1158/0008-5472.CAN-10-2705. Epub 2011 Feb 15. Cancer Res. 2011. PMID: 21324921 Free PMC article.

4

Systemic IL-12 administration alters hepatic dendritic cell stimulation capabilities.

Chan T, Back TC, Subleski JJ, Weiss JM, Ortaldo JR, Wiltrout RH. Chan T, et al. Among authors: weiss jm. PLoS One. 2012;7(3):e33303. doi: 10.1371/journal.pone.0033303. Epub 2012 Mar 13. PLoS One. 2012. PMID: 22428016 Free PMC article.

5

A matched couple: Combining kinase inhibitors with immunotherapy for cancer treatment.

Jiang Q, Weiss JM, Wiltrout RH. Jiang Q, et al. Among authors: weiss jm. Oncoimmunology. 2012 Jan 1;1(1):115-117. doi: 10.4161/onci.1.1.18036. Oncoimmunology. 2012. PMID: 22720229 Free PMC article.

6

Serum-based tracking of de novo initiated liver cancer progression reveals early immunoregulation and response to therapy.

Subleski JJ, Scarzello AJ, Alvord WG, Jiang Q, Stauffer JK, Kronfli A, Saleh B, Back T, Weiss JM, Wiltrout RH. Subleski JJ, et al. Among authors: weiss jm. J Hepatol. 2015 Nov;63(5):1181-9. doi: 10.1016/j.jhep.2015.06.021. Epub 2015 Jul 2. J Hepatol. 2015. PMID: 26143441 Free PMC article.

7

mTOR kinase inhibitor AZD8055 enhances the immunotherapeutic activity of an agonist CD40 antibody in cancer treatment.

Jiang Q, Weiss JM, Back T, Chan T, Ortaldo JR, Guichard S, Wiltrout RH. Jiang Q, et al. Among authors: weiss jm. Cancer Res. 2011 Jun 15;71(12):4074-84. doi: 10.1158/0008-5472.CAN-10-3968. Epub 2011 May 3. Cancer Res. 2011. PMID: 21540234 Free PMC article.

8

The split personality of NKT cells in malignancy, autoimmune and allergic disorders.

Subleski JJ, Jiang Q, Weiss JM, Wiltrout RH. Subleski JJ, et al. Among authors: weiss jm. Immunotherapy. 2011 Oct;3(10):1167-84. doi: 10.2217/imt.11.117. Immunotherapy. 2011. PMID: 21995570 Free PMC article. Review.

9

NOS2 enhances KRAS-induced lung carcinogenesis, inflammation and microRNA-21 expression.

Okayama H, Saito M, Oue N, Weiss JM, Stauffer J, Takenoshita S, Wiltrout RH, Hussain SP, Harris CC. Okayama H, et al. Among authors: weiss jm. Int J Cancer. 2013 Jan 1;132(1):9-18. doi: 10.1002/ijc.27644. Epub 2012 Jun 13. Int J Cancer. 2013. PMID: 22618808 Free PMC article.

10

Immunotherapeutic modulation of the suppressive liver and tumor microenvironments.

Chan T, Wiltrout RH, Weiss JM. Chan T, et al. Among authors: weiss jm. Int Immunopharmacol. 2011 Jul;11(7):879-89. doi: 10.1016/j.intimp.2010.12.024. Epub 2011 Jan 15. Int Immunopharmacol. 2011. PMID: 21241810 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

621 results

Search Page

Filters